Utah Medical Products (NASDAQ:UTMD) Stock Passes Below 200-Day Moving Average – What’s Next?

Utah Medical Products, Inc. (NASDAQ:UTMD) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $58.26 and traded as low as $57.12. Utah Medical Products shares last traded at $57.39, with a volume of 10,823 shares.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Utah Medical Products in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

Utah Medical Products Trading Down 1.4%

The business’s fifty day moving average is $57.30 and its 200 day moving average is $58.27. The company has a market cap of $181.12 million, a P/E ratio of 15.99 and a beta of 0.33.

Utah Medical Products (NASDAQ:UTMD) last announced its quarterly earnings data on Thursday, October 23rd. The medical instruments supplier reported $0.82 earnings per share for the quarter. Utah Medical Products had a return on equity of 9.89% and a net margin of 30.08%.The business had revenue of $9.81 million during the quarter.

Utah Medical Products Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, January 5th. Stockholders of record on Tuesday, December 16th will be paid a dividend of $0.31 per share. This represents a $1.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date is Tuesday, December 16th. This is a positive change from Utah Medical Products’s previous quarterly dividend of $0.31. Utah Medical Products’s dividend payout ratio is currently 35.03%.

Institutional Investors Weigh In On Utah Medical Products

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Brandes Investment Partners LP grew its position in shares of Utah Medical Products by 12.0% in the second quarter. Brandes Investment Partners LP now owns 271,322 shares of the medical instruments supplier’s stock valued at $15,444,000 after purchasing an additional 29,073 shares in the last quarter. Hotchkis & Wiley Capital Management LLC lifted its holdings in Utah Medical Products by 35.2% during the 1st quarter. Hotchkis & Wiley Capital Management LLC now owns 101,640 shares of the medical instruments supplier’s stock worth $5,696,000 after purchasing an additional 26,460 shares in the last quarter. Segall Bryant & Hamill LLC bought a new position in Utah Medical Products in the 3rd quarter worth about $726,000. Huber Capital Management LLC grew its holdings in Utah Medical Products by 38.9% during the 1st quarter. Huber Capital Management LLC now owns 39,819 shares of the medical instruments supplier’s stock valued at $2,231,000 after buying an additional 11,149 shares in the last quarter. Finally, Quantinno Capital Management LP purchased a new position in Utah Medical Products during the 2nd quarter valued at about $608,000. 69.60% of the stock is currently owned by institutional investors.

Utah Medical Products Company Profile

Utah Medical Products, Inc (NASDAQ: UTMD), headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single‐use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non‐invasive monitoring products used in acute and long‐term care settings.

The company’s core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end‐tidal carbon dioxide (CO₂).